Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Informa PLC Director's Dealing 2019

Apr 3, 2019

4915_dirs_2019-04-03_a57594e2-9408-40c5-8125-b5482c813a14.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0414V

Informa PLC

03 April 2019

INFORMA PLC

(the "Company")

Notification of transaction by Director/PDMR

On 3 April 2019, the Company was notified that yesterday (2 April), Greg Lock, Non-Executive Director and Deputy Chairman, transferred 50,000 Ordinary Shares of 0.1 pence each in the Company to The Greg and Rosie Lock Foundation (the "Lock Foundation") for nil consideration.  The Lock Foundation is a charitable trust (Charity number 1090360) established to support a broad range of charities with some emphasis on education and sport.  Greg Lock is a Trustee, but not a beneficiary, of the Lock Foundation, which is considered to be a Person Closely Associated with him.

Following this transaction, the Lock Foundation holds 50,000 shares in the Company.

These transactions took place outside of a trading venue.

This notification is made in accordance with the requirements of the EU Market Abuse Regulations.

Enquiries:

Heledd Hanscomb

Interim Deputy Company Secretary

Tel: + 44 (0)20 7017 5000

LEI: 5493006VM2LKUPSEDU20

Identification Code: GB00BMJ6DW54

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHGMGGDKFGGLZM